BackQuantum BioPharma Overview

Quantum BioPharma Cost of Revenue

Cost of Revenue analysis for QNTM.

Quarterly Cost of Revenue

$125670.00
2.81% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$257029.00
48.33% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)